U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT06800768) titled 'The Value of 68Ga-FAPI PET/CT in Detecting Recurrent and Metastatic Lesions in Patients with Thyroid Cancer After Surgery' on Jan. 24.
Brief Summary: This study aims to investigate the value of 68Ga-FAPI PET/CT in detecting recurrent and metastatic lesions in patients with thyroid cancer after surgery.
Study Start Date: Feb. 01
Study Type: OBSERVATIONAL
Condition:
Thyroid Cancer
Recruitment Status: RECRUITING
Sponsor: Ruijin Hospital
Information provided by (Responsible Party): Hu Jiajia, Ruijin Hospital
Disclaimer: Curated by HT Syndication....